Weighing the hazards of erythropoiesis stimulation in patients with cancer

MeSH terms

• Advisory Committees
• Anemia / drug therapy*
• Anemia / etiology
• Darbepoetin alfa
• Drug Labeling / legislation & jurisprudence
• Drug and Narcotic Control*
• Epoetin Alfa
• Erythropoiesis / drug effects*
• Erythropoietin / adverse effects*
• Erythropoietin / analogs & derivatives*
• Hematinics / adverse effects*
• Humans
• Neoplasms / complications
• Neoplasms / mortality*
• Neoplasms / pathology
• Recombinant Proteins
• Risk
• Stimulation, Chemical
• Thromboembolism / chemically induced
• United States
• United States Food and Drug Administration